Journal of Psychosomatic Research
Volume 68, Issue 5 , Pages 461-468 , May 2010

Dysfunction of stress responsive systems as a risk factor for functional somatic syndromes

  • Lineke M. Tak
    • ,
  • Judith G.M. Rosmalen

      Affiliations

    • Corresponding Author InformationCorresponding author. Interdisciplinary Center for Psychiatric Epidemiology, CC72, University Medical Center Groningen, University of Groningen, Hanzeplein 1, 9700 RB, Groningen, The Netherlands. Tel.: +31 50 361 1242; fax: +31 50 361 9722.

Received 30 October 2009 ,Revised 8 December 2009 ,Accepted 8 December 2009.

References 

  1. Deary V, Chalder T, Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev. 2007;27:781–797
  2. Van Houdenhove B, Egle U, Luyten P. The role of life stress in fibromyalgia. Curr Rheumatol Rep. 2005;7:365–370
  3. Mayer EA, Naliboff BD, Chang L, Coutinho SV. Stress and irritable bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2001;280:G519–G524
  4. McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med. 1998;338:171–179
  5. Genuth SM. The hypothalamus and pituitary gland. In:  Berne RM,  Levy RL editor. Physiology. 4th ed.. Missouri: Mosby; 1998;p. 872–909
  6. Willis WD. The autonomic nervous system and its central control. In:  Berne RM,  Levy RL editor. Physiology. 4th ed.. Missouri: Mosby; 1998;p. 233–248
  7. Miller GE, Chen E, Zhou ES. If it goes up, must it come down? Chronic stress and the hypothalamic-pituitary-adrenocortical axis in humans. Psychol Bull. 2007;133:25–45
  8. Dishman RK, Nakamura Y, Garcia ME, Thompson RW, Dunn AL, Blair SN. Heart rate variability, trait anxiety, and perceived stress among physically fit men and women. Int J Psychophysiol. 2000;37:121–133
  9. Lucini D, Di FG, Parati G, Pagani M. Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension. 2005;46:1201–1206
  10. Cleare AJ. The neuroendocrinology of chronic fatigue syndrome. Endocr Rev. 2003;24:236–252
  11. Tak LM, Rosmalen JGM. Psychoneuroendocrinology of functional somatic disorders. In:  Czberska MT editors. Psychoneuroendocrinology research trends. Hauppage, NY: Nova Science Publishers, Inc.; 2007;p. 463–495
  12. Heim C, Ehlert U, Hellhammer DH. The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders. Psychoneuroendocrinology. 2000;25:1–35
  13. Rief W, Barsky AJ. Psychobiological perspectives on somatoform disorders. Psychoneuroendocrinology. 2005;30:996–1002
  14. Sharpe M, Bass C. Pathophysiological mechanisms in somatization. Int Rev Psychiatry. 1992;4:81–97
  15. Kraemer HC, Kazdin AE, Offord DR, Kessler RC, Jensen PS, Kupfer DJ. Coming to terms with the terms of risk. Arch Gen Psychiatry. 1997;54:337–343
  16. Tak LM, Riese H, De Bock GH, Manoharan A, Kok IC, Rosmalen JG. As good as it gets? A meta-analysis and systematic review of methodological quality of heart rate variability studies in functional somatic disorders. Biol Psychol. 2009;82:101–110
  17. Boneva RS, Decker MJ, Maloney EM, Lin JM, Jones JF, Helgason HG, et al. Higher heart rate and reduced heart rate variability persist during sleep in chronic fatigue syndrome: a population-based study. Auton Neurosci. 2007;137:94–101
  18. Tak LM, Janssens KA, Dietrich A, Slaets JP, Rosmalen JG. Age-specific associations between cardiac vagal activity and functional somatic symptoms: a population-based study. Psychother Psychosom. 2009;(in press)
  19. Jindal RD, Vasko RC, Jennings JR, Fasiczka AL, Thase ME, Reynolds CF. Heart rate variability in depressed elderly. Am J Geriatr Psychiatry. 2008;16:861–866
  20. Sandercock GR, Bromley PD, Brodie DA. The reliability of short-term measurements of heart rate variability. Int J Cardiol. 2005;103:238–247
  21. Houtveen JH, Rietveld S, de Geus EJ. Exaggerated perception of normal physiological responses to stress and hypercapnia in young women with numerous functional somatic symptoms. J Psychosom Res. 2003;55:481–490
  22. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology . Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93:1043–1065
  23. Rechlin T. The effect of amitriptyline, doxepin, fluvoxamine, and paroxetine treatment on heart rate variability. J Clin Psychopharmacol. 1994;14:392–395
  24. Nolan RP, Kamath MV, Floras JS, Stanley J, Pang C, Picton P, et al. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J. 2005;149:1137
  25. Tang YY, Ma Y, Fan Y, Feng H, Wang J, Feng S, et al. Central and autonomic nervous system interaction is altered by short-term meditation. Proc Natl Acad Sci U S A. 2009;106:8865–8870
  26. Sandercock GR, Bromley PD, Brodie DA. Effects of exercise on heart rate variability: inferences from meta-analysis. Med Sci Sports Exerc. 2005;37:433–439
  27. Sloan RP, Shapiro PA, DeMeersman RE, Bagiella E, Brondolo EN, McKinley PS, et al. The effect of aerobic training and cardiac autonomic regulation in young adults. Am J Public Health. 2009;99:921–928
  28. Rosmalen JGM, Tak LM, Ormel J, Wessely S, Kok I, Cleare A, Manorahan A. Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. American Psychosomatic Society Annual Meeting, March 10-13, 2010, Abstract 1234.
  29. Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, Rosmalen JG. Meta-analysis and meta-regression of HPA axis activity in functional somatic disorders. Abstract 68th Annual Scientific Meeting of the American Psychosomatic Society, Portland, 2010.
  30. Fabian LA, McGuire L, Page GG, Goodin BR, Edwards RR, Haythornthwaite J. The association of the cortisol awakening response with experimental pain ratings. Psychoneuroendocrinology. 2009;34:1247–1251
  31. Dahlgren A, Kecklund G, Theorell T, Akerstedt T. Day-to-day variation in saliva cortisol-Relation with sleep, stress and self-rated health. Biol Psychol. 2009;82:149–155
  32. Tak LM, Rosmalen JGM, Bakker SJL. Dysfunction of the hypothalamic-pituitary-adrenal-axis and functional somatic symptoms: a longitudinal cohort study in the general population. Psychoneuroendocrinology. 2009;34:869–877
  33. Cleare AJ. The HPA axis and the genesis of chronic fatigue syndrome. Trends Endocrinol Metab. 2004;15:55–59
  34. Tanriverdi F, Karaca Z, Unluhizarci K, Kelestimur F. The hypothalamo-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress. 2007;10:13–25
  35. Bouma EM, Riese H, Ormel J, Verhulst FC, Oldehinkel AJ. Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase and oral contraceptives. The TRAILS study. Psychoneuroendocrinology. 2009;34:884–893
  36. Wust S, Federenko I, Hellhammer DH, Kirschbaum C. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. Psychoneuroendocrinology. 2000;25:707–720
  37. Lariviere WR, Melzack R. The role of corticotropin-releasing factor in pain and analgesia. Pain. 2000;84:1–12
  38. Clauw DJ, Chrousos GP. Chronic pain and fatigue syndromes: overlapping clinical and neuroendocrine features and potential pathogenic mechanisms. Neuroimmunomodulation. 1997;4:134–153
  39. Fries E, Hesse J, Hellhammer J, Hellhammer DH. A new view on hypocortisolism. Psychoneuroendocrinology. 2005;30:1010–1016
  40. Adam EK, Hawkley LC, Kudielka BM, Cacioppo JT. Day-to-day dynamics of experience–cortisol associations in a population-based sample of older adults. Proc Natl Acad Sci U S A. 2006;103:17058–17063
  41. Candy B, Chalder T, Cleare AJ, Peakman A, Skowera A, Wessely S, et al. Predictors of fatigue following the onset of infectious mononucleosis. Psychol Med. 2003;33:847–855
  42. Rubin GJ, Hotopf M, Papadopoulos A, Cleare A. Salivary cortisol as a predictor of postoperative fatigue. Psychosom Med. 2005;67:441–447
  43. Kumari M, Badrick E, Chandola T, Adam EK, Stafford M, Marmot MG, et al. Cortisol secretion and fatigue: Associations in a community based cohort. Psychoneuroendocrinology. 2009;34:1476–1485
  44. McBeth J, Silman AJ, Gupta A, Chiu YH, Ray D, Morriss R, et al. Moderation of psychosocial risk factors through dysfunction of the hypothalamic-pituitary-adrenal stress axis in the onset of chronic widespread musculoskeletal pain: findings of a population-based prospective cohort study. Arthritis Rheum. 2007;56:360–371
  45. Buijs RM, van Eden CG, Goncharuk VD, Kalsbeek A. The biological clock tunes the organs of the body: timing by hormones and the autonomic nervous system. J Endocrinol. 2003;177:17–26
  46. Clow A, Thorn L, Evans P, Hucklebridge F. The awakening cortisol response: methodological issues and significance. Stress. 2004;7:29–37
  47. Chida Y, Steptoe A. Cortisol awakening response and psychosocial factors: a systematic review and meta-analysis. Biol Psychol. 2009;80:265–278
  48. Ambrogio AG, Pecori GF, Cavagnini F. Drugs and HPA axis. Pituitary. 2008;11:219–229
  49. Granger DA, Hibel LC, Fortunato CK, Kapelewski CH. Medication effects on salivary cortisol: Tactics and strategy to minimize impact in behavioral and developmental science. Psychoneuroendocrinology. 2009;34:1437–1448
  50. Abelson JL, Khan S, Liberzon I, Erickson TM, Young EA. Effects of perceived control and cognitive coping on endocrine stress responses to pharmacological activation. Biol Psychiatry. 2008;64:701–707
  51. Cleare AJ, Heap E, Malhi GS, Wessely S, O'Keane V, Miell J. Low-dose hydrocortisone in chronic fatigue syndrome: a randomised crossover trial. Lancet. 1999;353:455–458
  52. McKenzie R, O'Fallon A, Dale J, Demitrack M, Sharma G, Deloria M, et al. Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial. JAMA. 1998;280:1061–1066
  53. Clark S, Tindall E, Bennett RM. A double blind crossover trial of prednisone versus placebo in the treatment of fibrositis. J Rheumatol. 1985;12:980–983
  54. Henningsen P, Zipfel S, Herzog W. Management of functional somatic syndromes. Lancet. 2007;369:946–955
  55. Roberts AD, Papadopoulos AS, Wessely S, Chalder T, Cleare AJ. Salivary cortisol output before and after cognitive behavioural therapy for chronic fatigue syndrome. J Affect Disord. 2009;115:280–286
  56. Bonifazi M, Suman AL, Cambiaggi C, Felici A, Grasso G, Lodi L, et al. Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia. Psychoneuroendocrinology. 2006;31:1076–1086
  57. Roberts AD, Charler ML, Papadopoulos A, Wessely S, Chalder T, Cleare AJ. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome?. Psychol Med. 2009;39:1–8
  58. Prins JB, Bleijenberg G, Bazelmans E, Elving LD, de Boo TM, Severens JL, et al. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357:841–847
  59. Glass JM, Lyden AK, Petzke F, Stein P, Whalen G, Ambrose K, et al. The effect of brief exercise cessation on pain, fatigue, and mood symptom development in healthy, fit individuals. J Psychosom Res. 2004;57:391–398
  60. Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3:655–666
  61. Abeles AM, Pillinger MH, Solitar BM, Abeles M. Narrative review: the pathophysiology of fibromyalgia. Ann Intern Med. 2007;146:726–734
  62. Lane RD, Waldstein SR, Critchley HD, Derbyshire SW, Drossman DA, Wager TD, et al. The rebirth of neuroscience in psychosomatic medicine, Part II: clinical applications and implications for research. Psychosom Med. 2009;71:135–151
  63. Eriksen HR, Ursin H. Subjective health complaints, sensitization, and sustained cognitive activation (stress). J Psychosom Res. 2004;56:445–448
  64. Roelofs K, Spinhoven P. Trauma and medically unexplained symptoms towards an integration of cognitive and neuro-biological accounts. Clin Psychol Rev. 2007;27:798–820
  65. Christenfeld NJ, Sloan RP, Carroll D, Greenland S. Risk factors, confounding, and the illusion of statistical control. Psychosom Med. 2004;66:868–875
  66. Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed.. Hillsdale, New Jersey: Lawrence Earlbaum Associates; 1988;
  67. Sumathipala A. What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med. 2007;69:889–900
  68. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry. 2001;158:848–856

PII: S0022-3999(09)00509-1

doi: 10.1016/j.jpsychores.2009.12.004

Journal of Psychosomatic Research
Volume 68, Issue 5 , Pages 461-468 , May 2010

Article Tools

* Image Usage & Resolution